|Articles|September 13, 2010
FDA Revises Medical Device Regulations and Human Subject Protection Requirements
Advertisement
1980, FDA requires IRB review for NSR (non-significant risk) devices1981, FDA and Department of Health and Human Services revise regulations for human subject protection.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
2
Unlocking Unstructured Health Data: Scaling eSource-Enabled Clinical Trials
3
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
4
Applying AI to Automate Workflows Without Disrupting Sites
5